"epidermal glands called elaiophores" trang 14 - tải miễn phí từ tailieunhanh
OSU-03012 sensitizes breast cancers to lapatinib-induced cell killing: A role for Nck1 but not Nck2

OSU-03012 sensitizes breast cancers to lapatinib-induced cell killing: A role for Nck1 but not Nck2
11    31    1
Activity of EGFR-tyrosine kinase and ALK inhibitors for EML4–ALK-rearranged non–small–cell lung cancer harbored coexisting EGFR mutation

Activity of EGFR-tyrosine kinase and ALK inhibitors for EML4–ALK-rearranged non–small–cell lung cancer harbored coexisting EGFR mutation
5    36    1
Claudin 1 expression in basal-like breast cancer is related to patient age

Claudin 1 expression in basal-like breast cancer is related to patient age
13    54    1
Expression and significance of HMGB1, TLR4 and NF-κB p65 in human epidermal tumors

Expression and significance of HMGB1, TLR4 and NF-κB p65 in human epidermal tumors
10    46    1
Heparan sulfate mediates trastuzumab effect in breast cancer cells

Heparan sulfate mediates trastuzumab effect in breast cancer cells
13    32    1
Capecitabine and bevacizumab for non-resectable metastatic colorectal cancer patients: Final results from phase II AIO KRK 0105 trial

Capecitabine and bevacizumab for non-resectable metastatic colorectal cancer patients: Final results from phase II AIO KRK 0105 trial
7    46    1
Clinical instability of breast cancer markers is reflected in long-term in vitro estrogen deprivation studies

Clinical instability of breast cancer markers is reflected in long-term in vitro estrogen deprivation studies
11    29    1
Biomarkers of benefit from cetuximab-based therapy in metastatic colorectal cancer: Interaction of EGFR ligand expression with RAS/RAF, PIK3CA genotypes

Biomarkers of benefit from cetuximab-based therapy in metastatic colorectal cancer: Interaction of EGFR ligand expression with RAS/RAF, PIK3CA genotypes
12    44    1
Detection and characterization of classical and “uncommon” exon 19 Epidermal Growth Factor Receptor mutations in lung cancer by pyrosequencing

Detection and characterization of classical and “uncommon” exon 19 Epidermal Growth Factor Receptor mutations in lung cancer by pyrosequencing
9    52    1
TRAIL and proteasome inhibitors combination induces a robust apoptosis in human malignant pleural mesothelioma cells through Mcl-1 and Akt protein cleavages

TRAIL and proteasome inhibitors combination induces a robust apoptosis in human malignant pleural mesothelioma cells through Mcl-1 and Akt protein cleavages
10    69    1
A case of lung adenocarcinoma harboring EGFR mutation and EML4-ALK fusion gene

A case of lung adenocarcinoma harboring EGFR mutation and EML4-ALK fusion gene
4    53    1
Curcumin and synthetic analogs induce reactive oxygen species and decreases specificity protein (Sp) transcription factors by targeting microRNAs

Curcumin and synthetic analogs induce reactive oxygen species and decreases specificity protein (Sp) transcription factors by targeting microRNAs
12    51    1
Alterations in epidermal growth factor receptors 1 and 2 in esophageal squamous cell carcinomas

Alterations in epidermal growth factor receptors 1 and 2 in esophageal squamous cell carcinomas
10    54    1
Allelotypes of lung adenocarcinomas featuring ALK fusion demonstrate fewer onco- and suppressor gene changes

Allelotypes of lung adenocarcinomas featuring ALK fusion demonstrate fewer onco- and suppressor gene changes
10    38    1
Prediction of sensitivity to gefitinib/ erlotinib for EGFR mutations in NSCLC based on structural interaction fingerprints and multilinear principal component analysis

Prediction of sensitivity to gefitinib/ erlotinib for EGFR mutations in NSCLC based on structural interaction fingerprints and multilinear principal component analysis
13    44    1
EGFR Mutant Structural Database: Computationally predicted 3D structures and the corresponding binding free energies with gefitinib and erlotinib

EGFR Mutant Structural Database: Computationally predicted 3D structures and the corresponding binding free energies with gefitinib and erlotinib
10    72    1
Understanding the molecular basis of EGFR kinase domain/MIG-6 peptide recognition complex using computational analyses

Understanding the molecular basis of EGFR kinase domain/MIG-6 peptide recognition complex using computational analyses
16    49    1
Computational analyses of curcuminoid analogs against kinase domain of HER2

Computational analyses of curcuminoid analogs against kinase domain of HER2
13    24    1
Coupled mutation finder: A new entropybased method quantifying phylogenetic noise for the detection of compensatory mutations

Coupled mutation finder: A new entropybased method quantifying phylogenetic noise for the detection of compensatory mutations
12    25    1
Pre-clinical study of IRDye800CWnimotuzumab formulation, stability, pharmacokinetics, and safety

Pre-clinical study of IRDye800CWnimotuzumab formulation, stability, pharmacokinetics, and safety
13    22    1